Product NDC: | 17478-547 |
Proprietary Name: | Granisetron Hydrochloride |
Non Proprietary Name: | Granisetron Hydrochloride |
Active Ingredient(s): | .1 mg/mL & nbsp; Granisetron Hydrochloride |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 17478-547 |
Labeler Name: | Akorn Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA079119 |
Marketing Category: | ANDA |
Start Marketing Date: | 20091001 |
Package NDC: | 17478-547-01 |
Package Description: | 10 VIAL, GLASS in 1 CARTON (17478-547-01) > 1 mL in 1 VIAL, GLASS |
NDC Code | 17478-547-01 |
Proprietary Name | Granisetron Hydrochloride |
Package Description | 10 VIAL, GLASS in 1 CARTON (17478-547-01) > 1 mL in 1 VIAL, GLASS |
Product NDC | 17478-547 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Granisetron Hydrochloride |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20091001 |
Marketing Category Name | ANDA |
Labeler Name | Akorn Inc. |
Substance Name | GRANISETRON HYDROCHLORIDE |
Strength Number | .1 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] |